GSK plc GLAXF

GLAXF Company Overview

GSK plc is a UK-based global biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines, specialty medicines, and general medicines. The company operates primarily in the biotechnology and pharmaceutical industries, with strategic emphasis on infectious diseases, immunology, oncology, respiratory diseases, and HIV treatment. GSK generates revenue through prescription pharmaceuticals and vaccines sold to healthcare providers, governments, wholesalers, and pharmacies worldwide. Its largest revenue contributors in recent years have included its vaccines portfolio and HIV-related therapies developed through its majority-owned subsidiary ViiV Healthcare.

The company traces its origins to several historic British pharmaceutical and consumer health businesses, including Glaxo Wellcome and SmithKline Beecham, which merged in 2000 to form GlaxoSmithKline. In 2022, the company separated its consumer healthcare division into an independent publicly traded company, Haleon, allowing GSK to concentrate exclusively on biopharmaceutical innovation. GSK positions itself competitively through a combination of vaccine scale, infectious disease expertise, long-term HIV leadership, and advanced R&D capabilities supported by genomics and immune system science.